16 November 2018 - Rep. Larry Bucshon on Friday criticised a drug pricing proposal President Trump made last month, marking some of the first public resistance to the move from congressional Republicans.

Bucshon told The Hill that Trump’s proposal to lower some drug prices in Medicare by tying them to cheaper prices in other countries is too far of a move toward “price controls.”

“It's not the direction that I would take,” Bucshon, a member of the House Energy and Commerce Committee, which oversees the issue, said. “I understand that we do want to get drug prices down but I think that any proposal that would lead to government price-fixing in that space is a pathway we don't want to follow.”

Read The Hill article